SLFN11 and cancer: Others also found that SLFN11 knockdown conferred resistance to an alkylating agent and PARP inhibitors; these drugs induced downregulation of SLFN11 levels in cancer cells, potentially explaining the link between low SLFN11 levels and chemoresistance [29, 30].